| Literature DB >> 1657143 |
W D Picking1, W Kudlicki, G Kramer, B Hardesty, J R Vandenheede, W Merlevede, I K Park, A DePaoli-Roach.
Abstract
Phosphatase inhibitor 2 was mutagenized and expressed in Escherichia coli to produce a protein with a single cysteinyl residue at position 129. The newly introduced sulfhydryl group was labeled with a maleimide derivative of coumarin (CPM). The resulting fluorescent inhibitor 2 molecule (CPM-I2) retains biological activity and binds to the catalytic subunit of type 1 phosphatase (PP1-C) with a Kd similar to the Ki of native I2 (2-3 nM). Fluorescence anisotropy data indicate that kinase FA (glycogen synthase kinase 3) does not dissociate the CPM-I2.PP1-C complex but rather causes a conformational change in the I2 molecule that is retained even after the CPM-I2 is displaced by an excess of native I2. The fluorescence data presented here also indicate that okadaic acid and I2 are competitive for binding to PP1-C, even after kinase FA treatment of the CPM-I2.PP1-C complex.Entities:
Mesh:
Substances:
Year: 1991 PMID: 1657143 DOI: 10.1021/bi00106a028
Source DB: PubMed Journal: Biochemistry ISSN: 0006-2960 Impact factor: 3.162